High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$12.4M
$12,428,889
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Other
|
2026-03-25 | $468,820 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-03-25
$5,518,741Whale
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-03-25 | $5,518,741Whale | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-03-24 | $5,959 | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Other
|
2026-03-24 | $506 | M | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Other
|
2026-01-27 | $87,787 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-27
$338,417
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-27 | $338,417 | S | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-26
$1,193,930Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-26 | $1,193,930Large | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Other
|
2026-01-26 | $44,984 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-26
$897,540
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-26 | $897,540 | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Other
|
2026-01-26 | $306,544 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Discretionary Sell
2026-01-23
$1,633,856Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Discretionary Sell
|
2026-01-23 | $1,633,856Large | S | Form 4 |
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Other
|
2026-01-23 | $81,316 | M | Form 4 |
|
PTGX
S
Protagonist Therapeutics, Inc
PATEL DINESH V PH D
• CEO
Sell to Cover
2026-01-20
$2,840,446Large
|
||||||
| PTGX |
Protagonist Therapeutics, Inc
|
CEO
Sell to Cover
|
2026-01-20 | $2,840,446Large | S | Form 4 |